West Pharmaceutical Services Inc. (WST) revealed a profit for its third quarter that Increased from last year and beat the Street estimates.
The company's bottom line totaled $140.00 million, or $1.92 per share. This compares with $136.00 million, or $1.85 per share, last year.
Excluding items, West Pharmaceutical Services Inc. reported adjusted earnings of $142.40 million or $1.96 per share for the period.
Analysts on average had expected the company to earn $1.69 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 7.7% to $804.60 million from $746.90 million last year.
West Pharmaceutical Services Inc. earnings at a glance (GAAP) :
-Earnings: $140.00 Mln. vs. $136.00 Mln. last year.-EPS: $1.92 vs. $1.85 last year.-Revenue: $804.60 Mln vs. $746.90 Mln last year.
-Guidance:Next quarter EPS guidance: $1.81 - $1.86Next quarter revenue guidance: $790 Mln - $800 Mln
The Company is increasing its FY25 adjusted-diluted EPS guidance range to $7.06 - $7.11, up from the previous range of $6.65 - $6.85.
The Company is also increasing its FY25 net sales guidance range to $3.060 Bln. - $3.070 Bln., up from $3.040 Bln - $3.060 Bln
For comments and feedback contact: editorial@rttnews.com
August 21, 2026 14:42 ET The minutes of the latest policy meeting of the Federal Reserve, housing market data and manufacturing sector survey results were the main news for the U.S. economy this week. In Europe, inflation data from the U.K. was the highlight, while consumer price data from Japan drew attention in Asia.